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BACKGROUND: The Chronic Care Model is an effective
framework for improving chronic disease management.
There is scarce literature describing this model for
people living with HIV. Decision Support (DS) and
Clinical Information Systems (CIS) are two components
of this model that aim to improve care by changing
health care provider behavior.
OBJECTIVE: Our aim was to assess the effectiveness of
DS and CIS interventions for individuals with HIV,
through a systematic literature review.
DESIGN: We performed systematic electronic
searches from 1996 to February 2011 of the medical
(E.g. Medline, EMBASE, CINAHL) and grey literature.
Effectiveness was measured by the frequency of sta-
tistically significant outcome improvement. Data and
key equity indicator extraction and synthesis was
completed.
PARTICIPANTS AND INTERVENTIONS: We included
comparative studies of people living with HIV that
examined the impact of DS or CIS interventions on
outcomes.
MAIN MEASURES: The following measures were
assessed: outcome (immunological/virological, medical,
psychosocial, economic measures) and health care
process/performance measures.
KEY RESULTS: Records were screened for relevance
(n=10,169), full-text copies of relevant studies were
obtained (n=123), and 16 studies were included in the
review. Overall, 5/9 (55.6%) and 17/41 (41.5%) pro-
cess measures and 5/12 (41.7%) and 3/9 (33.3%)
outcome measures for DS and CIS interventions,
respectively, were statistically significantly improved.
DS–explicit mention of implementation of guidelines
and CIS-reminders showed the most frequent im-
provement in outcomes. DS-only interventions were
more effective than CIS-only interventions in improving
both process and outcome measures. Clinical, statistical
and methodological heterogeneity among studies pre-
cluded meta-analysis. Primary studies were methodolog-
ically weak and often included multifaceted interventions
that made assessment of effectiveness challenging.
CONCLUSIONS: Overall, DS and CIS interventions may
modestly improve care for people living with HIV, having
a greater impact on process measures compared to
outcome measures. These interventions should be
considered as part of strategies to improve HIV care
through changing provider performance.
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INTRODUCTION
While the global incidence of HIV infection has stabilized,
the overall number of people living with HIV has steadily
increased, as HIV treatments extend life.1 In the developed
world, mortality from non-AIDS events now exceeds that
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of AIDS-defining opportunistic diseases in individuals
receiving effective antiretroviral therapy (ART).2,3 There
is an increasing role, particularly in high-resource settings,
for shifting our approach to HIV care from one of tertiary/
specialist care to one that includes the prevention and
treatment of common diseases.4–6 As HIV infection moves
into the realm of a chronic disease managed primarily in
the ambulatory setting, it is important to understand how
the principles of chronic disease management can be
applied to this population.
The Chronic Care Model (CCM; Wagner Model)7 is a
well-established framework for effective, evidence-based
clinical and quality improvement in chronic disease
management. CCM initiatives have become the foundation
of patient care for ischemic heart disease,8,9 congestive
heart failure,10–12 diabetes,10,11,13 asthma,10,11,13 chronic
obstructive pulmonary disease (COPD),14 and depression,10
and have been shown to improve patient-reported health
status and quality of life in primary care settings.15
However, literature on the application of the CCM
framework, and its elements for HIV management in the
primary care setting, is limited.
Decision Support (DS) and Clinical Information
Systems (CIS) are two elements of the CCM that
specifically target changing provider behavior to improve
patient care. DS interventions, such as the distribution of
educational materials, use of clinical practice guidelines,
and case discussions, emphasize the integration of evi-
dence-based guidelines into clinical practice. CIS inter-
ventions are based on establishing information systems to
organize patient data in order to improve the delivery of
care, such as by developing rosters of patients with certain
conditions and providing reminders.7 Several systematic
reviews have attempted to determine the effectiveness of
these elements on patient care, although clinical, method-
ological and statistical heterogeneity of the included
studies made data synthesis and generalizability diffi-
cult.10,16–18 As technology advances, DS and CIS inter-
ventions have become intertwined.16,18,19 In fact,
computerization of decision support tools is likely an
important feature contributing to their effectiveness.13,19
Some systematic reviews have examined the DS and CIS
elements explicitly in the context of the CCM frame-
work,10,13 in addition to many that have not directly
identified these components, but have studied interven-
tions that clearly fall under these categories.17–21 These
reviews demonstrate that DS and CIS interventions are
often successful,10,13,17–22 although the magnitude of
effect may be modest17 and also more clearly improve
provider performance than patient health measures.10,13,18
The purpose of this systematic review is to describe the
application and effectiveness of DS and CIS interventions
for persons living with HIV, and to identify the successful
characteristics of these interventions.
METHODS
Protocol
A protocol for record eligibility was developed a priori.
However, record screening began prior to the launch of
PROSPERO, a prospective register of systematic review
protocols.
Eligibility Criteria
Population. Individuals known to be living with HIV with
no restrictions based on age, gender, geography, setting, or
transmission group.
Types of Interventions. Similar to the method of Zwar et
al.,13 intervention strategies for people living with HIV
were categorized according to the Effective Practice and
Organization of Care (EPOC) taxonomy of interventions
(http://epoc.cochrane.org/information-specific-epoc-
reviews, accessed June 1, 2012), pertaining to the DS or
CIS elements of the CCM. The EPOC taxonomy was used
because of its focus on interventions designed to improve
professional practice and delivery of health care, which fits
with the scope of this review. This taxonomy allows
mapping of the interventions to the elements of the CCM,
which facilitated a descriptive categorization of the
interventions.
Types of Comparison Groups. Studies without a
comparison group were excluded. Comparators included
usual care, another (non-CCM) intervention, or both.
Types of Assessment Measures. The effectiveness of
interventions in this review was evaluated by assessing
improvement in “outcome” measures and “healthcare
process/provider performance” measures, as defined by
Adair et al.23
Primary Measures of Assessment
We identified a priori the following “outcome” measures for
included studies:
1) Immunological or virological outcomes: CD4 count or
viral load
2) Medical outcomes: mortality of patients, progression
to AIDS, opportunistic infections and cancers, hospital-
izations, functional status/disability, adherence to medica-
tion, and change in at-risk behaviors
3) Psychosocial outcomes: an outcome measure for
quality of life or psychological health and well-being
5) Economic outcomes: information about healthcare
utilization (length of stay, emergency department visits,
visits to providers), costs of treating patients, and costs to
patients of healthcare received
“Healthcare process/provider performance” measures
were also assessed. While these were not selected a priori,
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they included any measures of processes that are assumed
to improve patient care, such as:
1) Health care professional adherence to guidelines
2) Proportion of patients on antiretrovirals
3) Proportion of patients on indicated prophylaxis
4) Rates of screening for HIV-related illness
5) Provision of counseling
6) Rates of appropriate vaccination
7) Identification of at-risk behaviors
8) Patient or provider satisfaction with care
Types of Studies. Randomized clinical trials (RCTs),
controlled clinical trials (CCTs), cohort studies, case-
control studies, and controlled before and after designs
were included.
Information Sources
The comprehensive literature search strategy was informed
by previous systematic reviews based on the CCM13 and
the HIV/AIDS5 literature (See Appendix 1, available
online), and was developed by an experienced medical
librarian.
We searched the literature from 1996 (the advent of
modern ART) to February 2011. First, we conducted a
search of electronic databases that cover international
literature in medical/health sciences, psychology, social
sciences and social work (including, but not restricted to,
MEDLINE, EMBASE, CINAHL, and Cochrane Library).
Second, hand searching was performed, as needed, within
reference lists of included studies. Third, we used an
Internet search strategy of grey literature to identify other
published and unpublished literature. Since some studies
that were published in 1996 or later included data
collected prior to 1996, a post-hoc decision was made to
exclude these studies; as they were pre-ART, interventions
and outcomes were not deemed relevant to current
practice.
Study selection
Records were combined into Distiller SR (http://systematic-
review.net/), a web-based systematic review reference man-
agement software program. Next, the database was filtered for
duplications to derive a unique set of records. We used five
stages to review the articles:
Stage 1: Screening. The titles and abstracts of records
identified by the search were screened using a checklist
within Distiller SR to eliminate titles/topics that were not
pertinent to the research question. Due to the large number
of records to be screened, 40 records were first screened
independently by two reviewers (CK, RD). The weighted
kappa score between reviewers was 0.99, thus subsequent
records were screened by only one reviewer. If there was
any uncertainty regarding inclusion/exclusion, the article
proceeded to Stage 2.
Stage 2: Verification of Eligibility Criteria. Using a priori
study eligibility criteria, full-text copies of the potentially
eligible studies were assessed by two reviewers (CK, AP,
RD) to determine whether they fulfilled the inclusion
criteria. The third reviewer resolved any disagreements.
Stage 3: Data Extraction. Data were extracted from each
included study using a standardized data extraction form. The
form was developed based on relevant literature in the area
and derived by one reviewer (RD). While the data extraction
form was not formally piloted and compared between
reviewers, a small sample of studies was used by one
reviewer (AP) to ensure that the form was comprehensive
and easy to understand.24 Data extracted included participant
demographics, study design, description of the DS or CIS
interventions, and measures of assessment.
Stage 4: Data Synthesis. Summary tables containing all
information abstracted from eligible studies were created.
Comparability of studies was assessed by careful review of
the population, interventions, comparators, and outcomes
by one reviewer (AP). If two or more comparable studies
were identified, a pooled estimate of effect was calculated
in a meta-analysis to explore the effectiveness of the
intervention. For studies looking at dichotomous data,
relative risk (RR), odds ratio (OR), and/or risk difference
are provided where reported. For continuous data, means
and standard deviations or standard errors were extracted
where available. For studies that were not comparable in
terms of population, intervention, comparator, or assessment
measures, a qualitative summary is provided. Outcomes were
deemed significant if the 95% confidence interval (CI) of
their effect estimate did not include unity. Where CIs were
not reported, we used a p-value of ≤0.05 (comparing
intervention and control groups) as indicating statistical
significance. We also described the improvement across
studies by the category of outcome and by taxonomy of DS
or CIS interventions.
Consideration of Equity in Data Extraction
and Synthesis25
It is likely that the success of DS and CIS interventions
aiming to improve health and health outcomes is affected
by the social determinants of health, and the context in
which the interventions are implemented. During data
collection, information was collected on the study patient
populations across those PROGRESS+dimensions most
likely to contribute to inequities (Appendix 2, available
online), as well as the transmission risk group which is
relevant to HIV care.18,23,35,42
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Stage 5: Risk of Bias. Each included study was assessed
by one reviewer (AP) for methodological quality, using
standardized risk of bias checklists. The Cochrane
Collaboration’s tool for assessing risk of bias was used
for RCTs, clinical controlled trials, and comparison
before and after studies. The Newcastle-Ottawa scales
were used for cohort studies and case control studies. As
there are no instruments validated for non-comparative
studies, no tool was used to assess risk of bias. Summary
figures were used to depict risk of bias in included
studies.24
RESULTS
We identified a total of 10,169 records (Figure 1). Our
review process eliminated 10,046 records. Two articles
were irretrievable, following extensive searches conducted
by two medical librarians. Sixteen articles remained and
were included.
Participants of Included Studies
The total number of HIV positive patients included in this
review is 29,897 across 13 studies. Two studies26,27
compared groups based on clinic/providers without reporting
numbers of patients, and one28 did not report the total number
of patients in the study. Of the studies reporting patients by
gender, all but one study that examined cervical screening29
comprised a sample of mostly males. The age range of
patients in all but one pediatric study was under 50 years.
Settings of Included Studies
Ten studies were conducted in the USA,2,26,29–36 three in
the UK/Europe,37–39 and three in sub-Saharan Africa.27,28,40
All studies examined care in the ambulatory setting.
Design of Included Studies
Thirteen of the 16 studies (81.3%) were observational in
design. Further details on the study designs can be found in
Figure 1 and Table 1.
Figure 1. Flow Diagram of Included Studies.
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Risk of Bias and Methodological Quality
of Included Studies
Risk of bias for included RCTs and controlled before and
after studies is presented in Appendix 3, Table 1 (available
online). Both RCTs used an appropriate method for
randomization, although it was unclear whether allocation
concealment was adequate in either. The risk of bias for
cohort, time-motion, and prospective time-series studies
was assessed using the Newcastle-Ottawa scale, and results
are presented in Appendix 3, available online, Table 2. Six
of these studies did not provide adequate information
regarding follow-up of patients,26,27,31,38–40 and another
seven did not provide any details regarding the control of
important confounding variables between the intervention
and control groups.26,27,31,34,36,38,39
Effects of DS and CIS Interventions
Nine out of 16 (56%) studies assessed only health care
process/performance measures, while three studies (19%)
examined only outcome measures. The remaining four out
of 16 studies assessed both types of measures. There was
significant heterogeneity of study design, patient popula-
tions, types of interventions and outcomes examined among
the studies (Table 1). Thus, a narrative summary of the
evidence is presented in the summary of included studies in
Appendix 4 (available online). While heterogeneity makes
comparisons across studies impossible, we have included
any effect estimates reported in the included studies for
maximum transparency.
Studies Evaluating only Decision Support Interventions.
There were four studies that looked at DS-only interventions:
one assessed the distribution of educational materials,34 one
included explicit mention of implementation of guidelines
into practice,37 and two involved communication and case
discussion35,36 interventions (Table 1). Two studies reported
process measures,34,37 and found 5/9 (55.6%) of measures
were significantly improved. Two studies reported outcome
measures,35,36 and found 5/12 (41.7%) of measures were
significantly improved (2/3 immunological/virological, 1/5
medical, 2/4 psychosocial). The DS intervention reporting
the highest proportion of significantly improved outcomes
was the explicit mention of implementation of guidelines,
with improvement in four out of five (80%) healthcare
process/performance measures.
Studies Evaluating only Clinical Information Systems
Interventions. There were nine included studies that looked
at CIS-only interventions: two examined reminders,30,41 two
examined audit and feedback,29,33,38 two examined presence
of quality monitoring28,31 and three studies examined both
reminders and changes in medical records systems.26,32,40 Of
the eight studies reporting process measures,26,28–32,38,41 17/
41 (41.5%) were statistically significantly improved. For the
three studies reporting outcome measures,31,32,40 3/9 (33.3%)
of outcomes were improved, and there was no discernable
pattern regarding the type of outcome measures that
improved or not. With a total of 9/17 (52.9%) improved
outcomes, the use of reminders was the most effective CIS
intervention.
Studies Evaluating Interventions Combining Decision
Support and Clinical Information Systems Interventions.
Three studies27,33,39 implemented both DS and CIS
interventions. One study (Gardner et al.33) used primarily
provider training (DS-educational meetings, along with
CIS-audit and feedback at one site only). Another (Morris
et al.27) performed a complex, task-shifting traineeship that
was primarily DS-educational meetings, but included CIS-
quality monitoring and CIS-audit and feedback. The third
study (Fonquernie et al.39) combined primarily CIS
interventions (CIS-reminders and CIS-changes to medical
records systems) with DS-explicit implementation of
guidelines. Two of these studies assessed both process and
outcome measures, while one looked at process measures
only. For process measures, the findings varied with a total
of 5/12 (41.7%) of measures improved; one study reported
4/8 (50%) measures as having improved, another reporting
1/1 measure as improved, and the third reporting no
improvement in process measures (0/3). All outcome
measures assessed in these studies showed statistically
significant improvement (3/3; two medical and one
psychosocial).
Study Features Relating to Outcome Improvement. As
heterogeneity precluded meta-analysis, we examined
whether study design, number of participants or study
setting was associated with effectiveness. In the two
RCTs, 0/4 of process measures and 2/8 (25%) of
outcome measures were improved, compared to 27/58
(46.6%) and 9/16 (56.3%) of process and outcome
measures, respectively, in the observational studies. In
studies with >1000 patients, 13/42 (30.1%) of process
measures and 4/9 (44.4%) of outcome measures were
improved, compared to 16/23 (69.6%) and 5/12% (41.7%)
of process and outcome measures in smaller (<1000
patients) studies. In addition, for the three largest studies
with several thousand participants each,31,32,34 only 3/16
(18.8%) of process measures and 1/6 (16.7%) of outcome
measures were significantly improved. Finally, the three
studies conducted in Africa27,28,40 versus Europe or North
America were all too different to assess the impact of
setting on the effectiveness of interventions.
Other Considerations
Equity indicators were poorly reported overall, and details
are outlined in Appendix 5 (available online). When
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reported, these indicators did not provide any significant
insights into the populations for which the interventions
were more effective compared to others.
DISCUSSION
Our review aimed to determine the effectiveness of
Decision Support and Clinical Information Systems inter-
ventions in improving the care of persons with HIV,
through the influence of provider behavior. There was
considerable heterogeneity between study populations,
settings, types of interventions, types of measures, and
methodological quality of the included studies. This
heterogeneity is consistent with existing literature exam-
ining the effectiveness of the Chronic Care Model10,16–18
for other conditions. While it is difficult to discern an
overall pattern from the results, several observations can
be made.
DS interventions were more likely than CIS interventions
to improve process and outcome measures. The DS
intervention most likely to be effective was the explicit
implementation of guidelines, although this intervention on
its own was implemented in only one study.37 This is
similar to findings by Zwar et al.,13 although these authors
also found DS-distribution of educational materials to be
more effective in other conditions than we did for HIV, and
found DS-educational meetings to be effective, while our
review did not identify any studies examining this inter-
vention. The most frequently effective CIS intervention in
our review was the implementation of provider reminders,
which was reported to improve health care process/provider
performance outcomes in two studies.30,41 The least
effective CIS intervention was audit and feedback. Identi-
fying reminders as highly effective is consistent with Davis
et al.20 and with Garg et al.,18 who found reminders to be
the most effective form of computerized decision support.
However, this finding is in contrast to Zwar et al.13 who
found CIS-audit and feedback to be more effective for other
conditions than we did for HIV. The magnitude of effect,
which varies among studies, is consistent with previous
work defining improvements as significant but of modest
effect size.10,17,22
Studies assessing a combination of DS/CIS interven-
tions were less likely than DS-only and equally likely to
CIS-only interventions to improve process measures, and
more likely to report improved outcome measures,
although this number of studies is too small for definitive
comparison. These findings add to the debate in the
literature regarding whether the CCM must be imple-
mented into practice as a whole, or whether individual
elements can improve chronic disease management. The
reality is that most interventions are multifacet-
ed,10,11,13,16,17,21 and while some reviews have found
that more than one intervention within or across CCM
elements may be more effective than a single interven-
tion,11,16,20 others have not.10,13,17
The number of RCTs was small and their risk of bias
high, and these studies showed less effectiveness than those
in observational study designs. In addition, larger studies
were less likely to result in improved measures than smaller
studies. Publication bias may have resulted in smaller,
negative trials not being published.
Our work is consistent with previous reviews describing
that DS and CIS interventions improve care, although we
found a smaller proportion of improved outcomes than other
reviews.17,18 Certain features of DS and CIS interventions
improve their effectiveness, including the intensity of the
intervention;16,22 the presence of a preceding practice-
specific needs assessment;20 the involvement of the providers
in the development of guidelines,13 process integra-
tion,13,19,20 the use of computer-based systems;16,19 and the
provision of the reminder to patients themselves.13 The
studies included in this review do not provide sufficient
detail to extrapolate these potentially successful features to
the setting of HIV/AIDS care. As with previous literature, we
found that, overall, DS and CIS interventions improve
processes of care, but that these improvements do not clearly
translate into improved patient outcomes.10,13,18,22,42
This systematic review has several important limitations.
First, our summary and synthesis is limited by the methods
used in the primary studies, most of which were of
observational design and lacked detailed descriptions of
the interventions, a common pitfall of health care re-
search.43 Second, studies included in the review did not
monitor the long-term impact of the interventions that
would make them more applicable for use in routine clinical
practice.44 Third, there were a limited number of studies
examining each intervention and outcome. The clinical
heterogeneity of these interventions, outcomes and popula-
tions precluded our ability to perform a meta-analysis.
Finally, many of the studies included multiple interventions,
often across both DS and CIS categories, or were multifac-
eted to the extent that attributing effectiveness to one
component of the intervention was difficult.45
Overall, DS and CIS interventions may modestly improve
care for people living with HIV, with process measures more
likely to be improved than definitive outcome measures.
However, the limitations of the included studies precluded us
from delineating the ingredients that influence effectiveness.
Future studies aiming to change provider behavior through
the implementation of DS and CIS interventions for people
with HIV should use experimental, rather than observational,
methodologies in larger samples of patients. Interventions
should be described in detail43 and attention paid to known
facilitating characteristics of effective DS and CIS interven-
tions, especially when implemented in a broader quality
improvement or CCM initiative. In addition, the importance
of equity indicators in the design, implementation, and
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evaluation of interventions should be considered and
reported.25 Finally, in addition to intermediate measures of
process of care, studies should be extended to determine
whether sustained and clinically significant differences can
be found in patient-level outcomes.
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